🇺🇸 FDA
Patent

US 9801863

Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis

granted A61KA61K31/4365A61K31/444

Quick answer

US patent 9801863 (Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis) held by The Board of Regents of the University of Texas System expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4365, A61K31/444, A61K31/495, A61K31/496